• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in
Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in

... secretory protein could underlie neurodegenerative diseases. Investigation of disease-related changes in BDNF transport might provide insights into the cellular mechanism underlying, for example, Alzheimer’s disease (AD). To analyze the role of BDNF transport in AD, live cell imaging of fluorescentl ...
Niemann-Pick Disease Type C: A Lipid Trafficking
Niemann-Pick Disease Type C: A Lipid Trafficking

Contracted Assessment Report - Medical Services Advisory
Contracted Assessment Report - Medical Services Advisory

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and

Vestibular Disorders
Vestibular Disorders

PDF - Journal of Neuroscience
PDF - Journal of Neuroscience

A Critical Review of Secondary Neurodegeneration
A Critical Review of Secondary Neurodegeneration

Clinical and audiological features of Ménière’s disease:
Clinical and audiological features of Ménière’s disease:

CJD and other Prion Diseases - Creutzfeldt
CJD and other Prion Diseases - Creutzfeldt

Creutzfeldt-Jakob Disease Foundation
Creutzfeldt-Jakob Disease Foundation

Alzheimer`s Dementia
Alzheimer`s Dementia

A zebrafish model of CLN2 disease is deficient in
A zebrafish model of CLN2 disease is deficient in

PSP: Some Answers
PSP: Some Answers

À propos du présent document de consultation
À propos du présent document de consultation

Zinc Neurotoxicity and its Role in Neurodegenerative Diseases
Zinc Neurotoxicity and its Role in Neurodegenerative Diseases

Electrolytic lesion of globus pallidus ameliorates the behavioral and
Electrolytic lesion of globus pallidus ameliorates the behavioral and

Transglutaminase Is Linked to Neurodegenerative Diseases
Transglutaminase Is Linked to Neurodegenerative Diseases

... inclusions and intranuclear inclusions of mutant huntingtin are prominent neuropathologic hallmarks (23Y27). Transglutaminase-catalyzed cross-links are present in neuronal nuclei in selectively vulnerable brain regions in HD and the cross-links colocalize with the huntingtin protein in the inclusion ...
Claim Validity
Claim Validity

Epidemiology of Aging and Hearing Loss Related to Other
Epidemiology of Aging and Hearing Loss Related to Other

Curable Sensorineural Hearing Loss and Critical Hearing Loss
Curable Sensorineural Hearing Loss and Critical Hearing Loss

Gut Microbiota: A Modulator of Brain Plasticity and Cognitive
Gut Microbiota: A Modulator of Brain Plasticity and Cognitive

... impact of a gut completely absent of microbiota on behaviour. The foetal gut is sterile in-utero and maintaining these animals in a sterile environment after birth means that post-natal gut colonization does not occur. It further allows for the comparison of findings against control animals with a “ ...
Crohn`s disease - Wikipedia, the free encyclopedia
Crohn`s disease - Wikipedia, the free encyclopedia

PDF
PDF

CNB12 Plus
CNB12 Plus

From IDSA to ILADS: A Journey Toward
From IDSA to ILADS: A Journey Toward

< 1 2 3 4 5 6 ... 47 >

Alzheimer's disease



Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report